| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Johnson & Johnson (NYSE: JNJ)
JNJ Technical Analysis
5
| As on 9th Jun 2023 JNJ SHARE Price closed @ 160.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 171.90 & Strong Sell for SHORT-TERM with Stoploss of 168.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
JNJSHARE Price
| Open | 160.42 | Change | Price | % |
| High | 160.73 | 1 Day | -0.25 | -0.16 |
| Low | 159.47 | 1 Week | 4.95 | 3.19 |
| Close | 160.01 | 1 Month | -2.99 | -1.83 |
| Volume | 6264400 | 1 Year | -7.20 | -4.31 |
| 52 Week High 186.01 | 52 Week Low 151.05 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| JNJ Daily Charts |
JNJ Intraday Charts |
Whats New @ Bazaartrend |
JNJ Free Analysis |
|
|
JNJ Important Levels Intraday
| RESISTANCE | 162.44 |
| RESISTANCE | 161.66 |
| RESISTANCE | 161.18 |
| RESISTANCE | 160.70 |
| SUPPORT | 159.32 |
| SUPPORT | 158.84 |
| SUPPORT | 158.36 |
| SUPPORT | 157.58 |
JNJ Forecast April 2024
| 4th UP Forecast | 190.92 |
| 3rd UP Forecast | 181.01 |
| 2nd UP Forecast | 174.88 |
| 1st UP Forecast | 168.75 |
| 1st DOWN Forecast | 151.27 |
| 2nd DOWN Forecast | 145.14 |
| 3rd DOWN Forecast | 139.01 |
| 4th DOWN Forecast | 129.1 |
JNJ Weekly Forecast
| 4th UP Forecast | 168.06 |
| 3rd UP Forecast | 165.48 |
| 2nd UP Forecast | 163.88 |
| 1st UP Forecast | 162.29 |
| 1st DOWN Forecast | 157.73 |
| 2nd DOWN Forecast | 156.14 |
| 3rd DOWN Forecast | 154.54 |
| 4th DOWN Forecast | 151.96 |
JNJ Forecast2024
| 4th UP Forecast | 230.5 |
| 3rd UP Forecast | 207.89 |
| 2nd UP Forecast | 193.92 |
| 1st UP Forecast | 179.95 |
| 1st DOWN Forecast | 140.07 |
| 2nd DOWN Forecast | 126.1 |
| 3rd DOWN Forecast | 112.13 |
| 4th DOWN Forecast | 89.52 |
Johnson & Johnson ( NYSE USA Symbol : JNJ )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
JNJ Business Profile
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. Address: One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service